2008
DOI: 10.1055/s-0028-1088350
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of CYP1A1 by Quassinoids Found inPicrasma excelsa

Abstract: Infusions of the plant Picrasma excelsa, known as Jamaican bitterwood tea, are commonly consumed to lower blood sugar levels in diabetics who are already on prescription medicines. We therefore investigated the inhibition properties of this tea against a panel of cytochrome P450 (CYP) enzymes, which are primarily responsible for the metabolism of a majority of drugs on the market. The two major ingredients, quassin and neoquassin, were then isolated and used for further characterization. Inhibition of the acti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
28
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 23 publications
(30 citation statements)
references
References 13 publications
2
28
0
Order By: Relevance
“…To verify the accuracy of experimental techniques employed to detect CYP inhibition, assays with known inhibitors were carried out with furafylline (against CYP1A2), ketoconazole (against CYP1A1, CYP1B1 and CYP3A4), (−)-N-3-benzyl-phenobarbital (NBPB, against CYP2C19) and quinidine (against CYP2D6) and the obtained IC 50 values (0.8±0.2, 0.04±0.01, 6.3±1.7, 0.06±0.01, 0.3±191 0.01, and 0.03±0.01μM respectively) compared well with published values (0.99, b10, b10, 0.06, 0.25 and 0.01μM respectively; Shields, 2009;Badal et al, 2011;Powrie, 2010;Stresser et al, 2004;Cali, 2003 andMcLaughlin et al, 2008).…”
Section: Optimising Experimental Conditionssupporting
confidence: 71%
See 2 more Smart Citations
“…To verify the accuracy of experimental techniques employed to detect CYP inhibition, assays with known inhibitors were carried out with furafylline (against CYP1A2), ketoconazole (against CYP1A1, CYP1B1 and CYP3A4), (−)-N-3-benzyl-phenobarbital (NBPB, against CYP2C19) and quinidine (against CYP2D6) and the obtained IC 50 values (0.8±0.2, 0.04±0.01, 6.3±1.7, 0.06±0.01, 0.3±191 0.01, and 0.03±0.01μM respectively) compared well with published values (0.99, b10, b10, 0.06, 0.25 and 0.01μM respectively; Shields, 2009;Badal et al, 2011;Powrie, 2010;Stresser et al, 2004;Cali, 2003 andMcLaughlin et al, 2008).…”
Section: Optimising Experimental Conditionssupporting
confidence: 71%
“…As such we unlocked the interaction between quassin and CYP1A1 in previous publication (Shields et al, 2009). One of the first active site models for CYP1A1 was demonstrated with quasin and important residues were highlighted; Asp313, Thr11, Ser124, Phe123, Ile386 and Leu496 as shown in Fig.7 as being critical for binding quassinoids.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The aqueous extract of A. altilis inhibited CYPs3A4 and 2D6 enzyme activities in the sub mg/mL levels, which appear to be poor in potency. Other medicinal plant extracts have been noted to have IC 50 values ranging between 0.1 mg/mL (Shields et al, 2009) and more potent values of less than 0.01 mg/mL (Tam et al, 2009;Agbonon et al, 2010). Although conclusive determinations can only be drawn from clinical studies, the weak inhibition displayed by the A. altilis extract in this in vitro investigation is indicative of a fairly low likelihood of clinically observable adversities through CYPs3A4 and 2D6 mediated metabolism.…”
Section: Camentioning
confidence: 91%
“…Canthinone alkaloids and terpenoids can also elicit this kind of activity (Rivero-Cruz et al, 2005). In this context, Shields et al (2009) found that quassin and neoquassin inhibited the CYP1A1 isoenzyme, an isoform of the P450 cytochrome enzyme known for its carcinogenic activity, consequently assuming an important role as a chemoprotector (Shields et al, 2009). Simalikalactone D has also demonstrated a promising cytotoxic activity against mammary human adenocarcinoma cells .…”
Section: Cytotoxic Activitymentioning
confidence: 97%